date,title,source
Oct-30-18,3 Healthcare Stocks that Could Move on Industry Growth,ACCESSWIRE
Oct-30-18,Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation,PR Newswire
Oct-31-18,"Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018",PR Newswire
Nov-07-18,Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update,PR Newswire
Nov-28-18,5 Top-Ranked Rising P/E Stocks to Lure Investors,Zacks
Nov-29-18,"Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals",Zacks
Dec-18-18,Achieve Announces Update on Cytisinicline Clinical Development Program,PR Newswire
Dec-28-18,5 Top Rising P/E Stocks to Enjoy Solid Gains,Zacks
Feb-20-19,Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation,PR Newswire
Feb-22-19,Four Healthcare Stocks Looking to Close Out a Strong Week,ACCESSWIRE
Feb-22-19,Achieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial,MarketWatch
Feb-22-19,"Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting",PR Newswire
